Coumadin (warfarin Sodium Tablets, Usp) Trademark Details
Word Mark | Coumadin (Warfarin Sodium Tablets, Usp) |
---|---|
Status | Dead 602 — Abandoned-Failure to Respond or Late Response |
Current Owner
Bristol-Myers Squibb Pharma Company of Princeton, NJ
View all trademarks for Bristol-Myers Squibb Pharma CompanySerial Number | 86803382 |
---|---|
Status Date | Friday, September 30, 2016 |
Filing Date | Friday, September 30, 2016 |
Attorney | Marilyn F. Kelly |
Correspondent
MARILYN F. KELLY
Bristol-Myers Squibb Company
PO Box 4000
Joint Base Mdl, NJ 08640-0902
Bristol-Myers Squibb Company
PO Box 4000
Joint Base Mdl, NJ 08640-0902
Case File Statements
Indication of Colors | The color(s) red, purple, green, blue, orange, yellow and black is/are claimed as a feature of the mark. |
---|---|
Disclaimer with Predetermined Text | "(Warfarin Sodium Tablets, Usp)" |
Description of Mark | The mark consists of the words "COUMADIN (WARFARIN SODIUM TABLETS, USP)" in black stylized font and a design of a splash in the colors red, purple, green, blue, orange and yellow. |
Goods & Services | An anticoagulant pharmaceutical preparation |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, November 3, 2015 |
First Use Anywhere | Friday, April 12, 2002 |
First Use In Commerce | Friday, April 12, 2002 |
Primary Code | 005 |
Trademark Timeline
-
Apr 12 2002First use anywhere for the mark
-
Apr 12 2002First use in commerce for the mark
-
Oct 29 2015Trademark application filed with USPTO
-
Nov 02 2015New Application Entered In Tram
-
Nov 03 2015New Application Office Supplied Data Entered In Tram
-
Nov 04 2015Notice of Design Search Code E-Mailed
-
Feb 22 2016Assigned To Examiner
-
Feb 24 2016Notification of Non-Final Action E-Mailed
-
Feb 24 2016Non-Final Action E-Mailed
-
Feb 24 2016Non-Final Action Written
-
Sep 30 2016Abandonment Notice Mailed - Failure To Respond
-
Sep 30 2016Abandonment - Failure To Respond Or Late Response